CAPTRUST Financial Advisors
SPPI

CAPTRUST Financial Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-845
Closed -$1K – 4421
2022
Q2 		$1K Hold
845
– – ﹤0.01% 4813
2022
Q1 		$1K Sell
845
-370
-30% -$341 ﹤0.01% 4793
2021
Q4 		$2K Sell
1,215
-199
-14% -$356 ﹤0.01% 4472
2021
Q3 		$3K Sell
1,414
-3,224
-70% -$8.81K ﹤0.01% 4175
2021
Q2 		$17K Sell
4,638
-951
-17% -$3.31K ﹤0.01% 3235
2021
Q1 		$18K Buy
5,589
+5,104
+1,052% +$18.3K ﹤0.01% 3087
2020
Q4 		$2K Buy
485
+185
+62% +$761 ﹤0.01% 3181
2020
Q3 		$1K Buy
300
+100
+50% +$380 ﹤0.01% 2977
2020
Q2 		$1K Buy
+200
New +$583 ﹤0.01% 2763
2019
Q4 		– Sell
-200
Closed -$2K – 1917
2019
Q3 		$2K Hold
200
– – ﹤0.01% 1825
2019
Q2 		$2K Buy
+200
New +$1.79K ﹤0.01% 1830

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CAPTRUST Financial Advisors's SPPI Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 845 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in SPPI in Q2 2019 and held it in 11 quarters. The position peaked at $18K in Q1 2021. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 845 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Spectrum Pharmaceuticals Inc position peaked at $18K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.